Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link

Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.

Volume 31, Number 3—March 2025
Dispatch

Tsukamurella tyrosinosolvens Respiratory Infection in Immunocompetent Man

Aidan CliffordComments to Author , Jenny Siaw Jin Wong, Ben Aw-Yeong, Kerrie Lea, Maria Globan, and Benjamin Smith
Author affiliation: Western Health, Melbourne, Victoria, Australia (A. Clifford, B. Smith); Dorevitch Pathology, Melbourne (J. Siaw Jin Wong, B. Aw-Yeong); Victorian Infectious Disease Reference Laboratory at the Peter Doherty Institute for Infection and Immunity, Melbourne (M. Globan)

Main Article

Table

Antimicrobial susceptibility testing results for reported case of Tsukamurella tyrosinosolvens infection in 25-year-old immunocompetent man, with tentative interpretation based on Nocardia spp. breakpoints (14)*

Agent MIC, μg/mL Tentative interpretation
Amikacin 1 S
Amoxicillin/clavulanic acid 64/32 R
Ceftriaxone 4 S
Ciprofloxacin 0.5 S
Clarithromycin 2 S
Doxycycline 4 I
Imipenem 2 S
Linezolid 2 S
Minocycline 1 S
Moxifloxacin 0.25 S
Tobramycin 16 R
Trimethoprim/sulfamethoxazole 0.25/4.75 S

*I, intermediate; R, resistant; S, sensitive.

Main Article

References
  1. Safaei  S, Fatahi-Bafghi  M, Pouresmaeil  O. Role of Tsukamurella species in human infections: first literature review. New Microbes New Infect. 2017;22:6–12. DOIPubMedGoogle Scholar
  2. Yu  S, Ding  X, Hua  K, Zhu  H, Zhang  Q, Song  X, et al. Systematic investigation of the emerging pathogen of Tsukamurella species in a Chinese tertiary teaching hospital. Microbiol Spectr. 2023;11:e0164423. DOIPubMedGoogle Scholar
  3. Teng  JLL, Tang  Y, Wong  SSY, Fong  JYH, Zhao  Z, Wong  CP, et al. MALDI-TOF MS for identification of Tsukamurella species: Tsukamurella tyrosinosolvens as the predominant species associated with ocular infections. Emerg Microbes Infect. 2018;7:80. DOIPubMedGoogle Scholar
  4. Romano  L, Spanu  T, Calista  F, Zappacosta  B, Mignogna  S, Sali  M, et al. Tsukamurella tyrosinosolvens and Rhizobium radiobacter sepsis presenting with septic pulmonary emboli. Clin Microbiol Infect. 2011;17:1049–52. DOIPubMedGoogle Scholar
  5. Yang  L, Cao  Y, Dan  Z, Wang  Z, Wang  X. Community-acquired Tsukamurella pneumonia in a young immunocompetent adult: a case misdiagnosed as pulmonary tuberculosis and literature review. Postgrad Med. 2017;129:563–6. DOIPubMedGoogle Scholar
  6. Sandhu  JE, Ariyaratnam  J. D Trandafirescu T. Nocardia Tsukamurella: an atypical pneumonia. Chest. 2022;162(Supplement):A561. DOIGoogle Scholar
  7. Liu  X, Shi  J, Wang  X, Chen  Y, Zheng  L. Tsukamurella pneumonia misdiagnosed as pulmonary tuberculosis. Lancet Infect Dis. 2022;22:1090. DOIPubMedGoogle Scholar
  8. Kuge  T, Fukushima  K, Matsumoto  Y, Saito  H, Abe  Y, Akiba  E, et al. Chronic pulmonary disease caused by Tsukamurella toyonakaense. Emerg Infect Dis. 2022;28:1437–41. DOIPubMedGoogle Scholar
  9. Gotoh  K, Mayura  IPB, Hagiya  H, Obata  K, Ogawa  T, Iio  K, et al. Septic pulmonary emboli caused by Tsukamurella inchonensis: A case report. J Infect Chemother. 2021;27:369–72. DOIPubMedGoogle Scholar
  10. Swier  R, Jakharia  KK. Acid-fast bacteria in bronchiectasis: if the glass slipper does not fit, non-TB mycobacteria, consider Tsukamurella. Chest. 2022;162:A573. DOIGoogle Scholar
  11. Manek  G, Shah  N, Krishnan  AM, Anthony  P. A case of Tsukamurella pulmonis masquerading as pleural TB in an immunocompetent patient. Chest. 2019;156(Supplement):A252. DOIGoogle Scholar
  12. Akkineni  S, Calderon Candelario  RA, Mirsaeidi  M. Acute COPD exacerbation associated with a rare pathogen: a case of Tsukamurella pulmonis. Am J Respir Crit Care Med. 2019;199:A6448.
  13. Rao  S, Paz  M, Nugent  K. Tsukamurella and Mycobacterium tuberculosis pneumonia co-infection. Am J Med Sci. 2023;365:S163-S.
  14. Clinical and Laboratory Standards Institute. Susceptibility testing of mycobacteria, Nocardiae, and other aerobic actinomycetes. 2nd edition. Wayne (PA): The Institute; 2011 [cited 2024 Sep 24]. https://www.ncbi.nlm.nih.gov/books/NBK544374
  15. Sun  Q, Yan  J, Liao  X, Wang  C, Wang  C, Jiang  G, et al. Trends and species diversity of non-tuberculous Mycobacteria isolated from respiratory samples in Northern China, 2014-2021. Front Public Health. 2022;10:923968. DOIPubMedGoogle Scholar

Main Article

Page created: February 21, 2025
Page updated: February 21, 2025
Page reviewed: February 21, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external